Nuvation Bio (NUVB) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Nuvation Bio insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $118K and 6 sold $9.7M of NUVB stock on the open market.
Get emailed when insiders cluster-buy stocks like NUVB
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
NUVB insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $709K | 1 |
| Q2 2026 | $118K | 1 | $2.8M | 6 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $6.2M | 10 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Nuvation Bio Inc. insider reported open-market purchases totaling $118K, while 6 insiders reported sales totaling $9.7M. 8 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 21SEC | Gary HattersleyChief Scientific Officer | Sell Plan | 100,000 | $7.09 | $709K | -29.5% | — |
| Jun 24SEC | Stacy MarkelChief People Officer | Sell Plan | 125,00032,591 held (−79%) | $6.03 | $754K | -17.1% | — |
| Jun 24SEC | Kerry WentworthChief Regulatory Officer | Sell Plan | 63,00053,000 held (−54%) | $6.02 | $379K | -16.9% | — |
| Jun 24SEC | Philippe SauvageCFO | Sell Plan | 47,66812,673 held (−79%) | $6.01 | $286K | -16.8% | — |
| Jun 11SEC | Robert MashalDirector | Buy | 25,000225,000 held (+12%) | $4.73 | $118K | +5.7% | — |
| Apr 21SEC | Dongfang LiuChief Medical Officer | Sell Plan | 50,00018,000 held (−74%) | $5.02 | $251K | -0.4% | — |
| Apr 21SEC | Kerry WentworthChief Regulatory Officer | Sell Plan | 36,75053,000 held (−41%) | $5.01 | $184K | -0.2% | — |
| Apr 8SEC | Kerry WentworthChief Regulatory Officer | Sell Plan | 200,00053,000 held (−79%) | $4.52 | $904K | +10.6% | — |
| Dec 3SEC | Dongfang LiuChief Medical Officer | Sell | 150,00018,000 held (−89%) | $7.82 | $1.2M | -36.1% | — |
| Nov 26SEC | Dongfang LiuChief Medical Officer | Sell | 10,00018,000 held (−36%) | $8.00 | $80K | -37.5% | — |
| Nov 26SEC | Dongfang LiuChief Medical Officer | Sell | 10,00018,000 held (−36%) | $7.50 | $75K | -33.3% | — |
| Nov 24SEC | Gary HattersleyChief Scientific Officer | Sell | 300,000 | $7.23 | $2.2M | -30.8% | — |
| Nov 24SEC | Gary HattersleyChief Scientific Officer | Sell | 69,051 | $7.23 | $499K | -30.8% | — |
| Nov 24SEC | Dongfang LiuChief Medical Officer | Sell | 20,00018,000 held (−53%) | $7.00 | $140K | -28.6% | — |
| Nov 21SEC | David C. HanleyChief Technical Operations | Sell | 200,00024,000 held (−89%) | $7.14 | $1.4M | -30.0% | — |
| Nov 19SEC | Dongfang LiuChief Medical Officer | Sell | 15,00018,000 held (−45%) | $5.10 | $76K | -2.0% | — |
| Nov 19SEC | Dongfang LiuChief Medical Officer | Sell | 15,00015,000 held (−50%) | $4.77 | $72K | +4.8% | — |
| Oct 29SEC | Gary HattersleyChief Scientific Officer | Sell Plan | 100,000 | $5.02 | $502K | -0.4% | — |
Insiders at Nuvation Bio Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Gary HattersleyChief Scientific Officer | — | $3.9M | Aug 21, 2026 | — |
| Dongfang LiuChief Medical Officer | — | $1.9M | Apr 21, 2026 | — |
| Kerry WentworthChief Regulatory Officer | — | $1.5M | Jun 24, 2026 | — |
| David C. HanleyChief Technical Operations | — | $1.4M | Nov 21, 2025 | — |
| Stacy MarkelChief People Officer | — | $754K | Jun 24, 2026 | — |
| Robert MashalDirector | $118K | — | Jun 11, 2026 | — |
| Philippe SauvageCFO | — | $286K | Jun 24, 2026 | — |
NUVB stock: common questions
Are Nuvation Bio Inc. insiders buying NUVB stock?
In the past 12 months, 1 insiders reported open-market purchases of NUVB worth $118K. The latest was Director Robert Mashal bought $118K of NUVB at $4.73 — first open-market purchase in our records.
Are Nuvation Bio Inc. insiders selling NUVB stock?
6 insiders reported sales worth $9.7M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is NUVB's 52-week range?
Over the past year NUVB has traded between $3.41 and $9.54. It last closed at $5.00 on Oct 9, 2026.